Neos Therapeutics is Drug Discovery in United States that focus on Neos Therapeutics Inc business. Founded in 1994. They cover business area such as Neos Therapeutics Inc, manufacture, commercialization, product, attention deficit hyperactivity disorder, adhd, its drug delivery technology, Methylphenidate XR-ODT, Amphetamine XR, oral suspension commonly prescribe medicine, ADHD, addition, market, generic Tussionex, a hydrocodone polistirex, cough, revenue.
1994
( 30 years old in 2024 )
Neos Therapeutics Inc
-
2940 North Highway 360
Suite 400
Grand Prairie, TX 75050
United States
Private
Neos Therapeutics Incmanufacturecommercializationproductattention deficit hyperactivity disorderadhdits drug delivery technologyMethylphenidate XR-ODTAmphetamine XRoral suspension commonly prescribe medicineADHDadditionmarketgeneric Tussionexa hydrocodone polistirexcoughrevenue
* We use standard office opening hours in near Neos Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Neos Therapeutics is Drug Discovery business from United States that founded in 1994 (30 years old in 2024), Neos Therapeutics business is focusing on Neos Therapeutics Inc.
Neos Therapeutics headquarter office and corporate office address is located in 2940 North Highway 360 Suite 400 Grand Prairie, TX 75050 United States.
Neos Therapeutics was founded in United States.
In 2024, Neos Therapeutics is currently focus on Neos Therapeutics Inc sector.
Above is snippet of Google Trends for "Neos Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Neos Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
